お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974942

世界の次世代シーケンシングの市場予測・競合動向・成長機会 (~2025年):製品・技術・エンドユーザー・用途・地域別

Global Next-generation Sequencing Market, By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 153 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

世界の次世代シーケンシングの市場予測・競合動向・成長機会 (~2025年):製品・技術・エンドユーザー・用途・地域別
出版日: 2020年12月01日
発行: TechSci Research
ページ情報: 英文 153 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の次世代シーケンシングの市場規模は2019年の82億675万米ドから、予測期間中は19.59%のCAGRで成長すると予測されています。次世代シーケンシングをベースとした診断検査に関する規制の強化、次世代シーケンシングの進歩とNGSプラットフォームの価格の低下などの要因が同市場の成長を推進する見通しです。一方で、NGSベースの診断法の標準化に関する懸念が市場のさらなる成長の妨げとなる可能性があります。

技術別で見ると、合成シーケンス (SBS) の部門が2019年に73.04%のシェアを示し、予測期間中も堅調な成長を示すと予測されています。

当レポートでは、世界の次世代シーケンシングの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、世界および地域・国別の市場規模および市場シェアの推移・予測、製品・技術・エンドユーザー・用途など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品概要

第2章 調査手法

第3章 COVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
    • 消耗品
    • プラットフォーム
    • サービス
  • 技術別
    • 合成シーケンシング
    • イオン半導体シーケンシング
    • ライゲーションシーケンシング
    • 単一分子リアルタイムシーケンシングなど
  • エンドユーザー別
    • 学術・臨床研究センター
    • 製薬・バイオテクノロジー企業
    • 病院・診療所など
  • 用途別
    • バイオマーカー・癌
    • 診断
    • リプロダクティブヘルス
    • 個別化医療
    • 農業・動物研究など
  • 地域別
  • 企業別
  • 製品市場マップ

第7章 北米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別

第8章 欧州市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別

第9章 アジア太平洋市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別

第10章 中東・アフリカ市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別

第11章 南米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 製品別
  • 技術別
  • エンドユーザー別
  • 用途別
  • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • BGI Group
    • Perkinelmer Inc.
    • Agilent Technologies, Inc.
    • Pacific Biosciences of California Inc.
    • F. Hoffmann-La Roche Ltd.
    • 10x Genomics Inc.
    • Amgen Inc.
    • Takara Bio Inc.

第15章 戦略的提言

第16章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 2: Global Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 3: Global Next-Generation Sequencing Market Share, By Product, By Consumables, By Value, 2015-2025F
  • Figure 4: Global Next-Generation Sequencing Market Share, By Product, By Platforms, By Value, 2015-2025F
  • Figure 5: Global Next-Generation Sequencing Market Share, By Product, By Services, By Value, 2015-2025F
  • Figure 6: Global Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 7: Global Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 8: Global Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 9: Global Next-Generation Sequencing Market Share, By Company, By Value, 2019
  • Figure 10: Global Next-Generation Sequencing Market Share, By Region, By Value, 2019 & 2025F
  • Figure 11: Global Next-Generation Sequencing Market Map, By Product - Market Size (USD Million) & Growth Rate (%)
  • Figure 12:Global Next-Generation Sequencing Market Map, By Technology - Market Size (USD Million) & Growth Rate (%)
  • Figure 13: Global Next-Generation Sequencing Market Map, By End User - Market Size (USD Million) & Growth Rate (%)
  • Figure 14: Global Next-Generation Sequencing Market Map, By Application - Market Size (USD Million) & Growth Rate (%)
  • Figure 15: Global Next-Generation Sequencing Market Map, By Region - Market Size (USD Million) & Growth Rate (%)
  • Figure 16: North America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 17: North America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 18: North America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 19: North America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 20: North America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 21: North America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 22: United States Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 23: Total Human Genome Funding by National Institute for Health (NIH) in United States, USD Million, 2015-2019
  • Figure 24: United States Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 25: United States Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 26: United States Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 27: Canada Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 28: Canada Hospital Establishments, By Region, 2019 (Units)
  • Figure 29: Canada Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 30: Canada Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 31: Canada Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 32: Mexico Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 33: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 34: Mexico Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 35: Mexico Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 36: Mexico Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 37: Europe Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 38: Europe Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 39: Europe Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 40: Europe Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 41: Europe Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 42: Europe Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 43: United Kingdom Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 44: New Cancer Cases in United Kingdom (%), 2019
  • Figure 45: United Kingdom Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 46: United Kingdom Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 47: United Kingdom Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 48: Germany Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 49: New Cancer Cases in Germany (%), Females, All Ages, 2019
  • Figure 50: Germany Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 51: Germany Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 52: Germany Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 53: France Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 54: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 55: France Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 56: France Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 57: France Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 58: Italy Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 59: New Cancer Cases in Italy (%), Males, All Ages, 2019
  • Figure 60: Italy Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 61: Italy Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 62: Italy Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 63: Spain Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 64: Number of New Cancer Cases in Spain, By Cancer Site, 2019
  • Figure 65: Spain Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 66: Spain Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 67: Spain Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 68: Asia-Pacific Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 69: Asia-Pacific Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 70: Asia-Pacific Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 71: Asia-Pacific Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 72: Asia-Pacific Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 73: Asia-Pacific Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 74: China Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 75: New Cancer Cases in China (%), 2019
  • Figure 76: China Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 77: China Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 78: China Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 79: Japan Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
  • Figure 81: Japan Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 82: Japan Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 83: Japan Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 84: South Korea Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 85: New Cancer Cases in South Korea (%), 2019
  • Figure 86: South Korea Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 87: South Korea Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 88: South Korea Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 89: Australia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 90: % of Public and Private Hospitals in Australia, 2019
  • Figure 91: Australia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 92: Australia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 93: Australia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 94: India Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 95: New Cancer Cases in India (%), Both Sexes, All Ages, 2019
  • Figure 96: India Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 97: India Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 98: India Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 99: South America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 100: South America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 101: South America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 102: South America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 103: South America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 104: South America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 105: Brazil Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 106: Total Number of Hospitals in Brazil, 2015-2018
  • Figure 107: Brazil Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 108: Brazil Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 109: Brazil Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 110: Argentina Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 111: Argentina Health Expenditure (% of GDP), 2015-2019
  • Figure 112: Argentina Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 113: Argentina Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 114: Argentina Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 115: Colombia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 116: New Cancer Cases in Colombia (%), 2019
  • Figure 117: Colombia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 118: Colombia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 119: Colombia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 120: Middle East and Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 121: Middle East and Africa Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 122: Middle East and Africa Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 123: Middle East and Africa Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 124: Middle East and Africa Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 125: Middle East and Africa Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 126: UAE Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 127: UAE Health Expenditure (% of GDP), 2015-2019
  • Figure 128: UAE Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 129: UAE Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 130: UAE Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 131: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 132: Total Number of Hospitals in Saudi Arabia, 2015-2019
  • Figure 133: Saudi Arabia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 134: Saudi Arabia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 135: Saudi Arabia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 136: South Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 137: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 138: South Africa Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 139: South Africa Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 140: South Africa Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
目次
Product Code: 4508

Title:
Global Next-generation Sequencing Market, By Product (Consumables, Platforms and Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications), By Region, Competition, Forecast & Opportunities, 2025.

Global next-generation sequencing market was valued at USD 8206.75 Million in 2019 and is projected to grow at a CAGR of 19.59% during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.

The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 with share of 73.04% and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Perkinelmer Inc., Agilent Technologies, Inc., Pacific Biosciences of California Inc., F. Hoffmann-La Roche Ltd., 10x Genomics Inc., Amgen Inc., Takara Bio Inc. and others.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyse and forecast the market size of global next-generation sequencing market.
  • To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
  • To identify drivers and challenges for global next-generation sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
  • To conduct pricing analysis for global next-generation sequencing market.
  • To identify and analyse the profile of leading players operating in global next-generation sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Next-generation sequencing service providers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to next-generation sequencing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:

  • Consumables
  • Platforms
  • Services

Market, By Technology:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Single Molecule Real Time Sequencing
  • Other Technologies

Market, By End User:

  • Academic & Clinical Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Others

Market, By Application:

  • Biomarkers & Cancer
  • Diagnostics
  • Reproductive Health
  • Personalized Medicine
  • Agriculture & Animal Research
  • Other Applications

Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Next-Generation Sequencing (NGS) Market

4. Executive Summary

5. Voice of Customer

  • 5.1. By Brand Recall
  • 5.2. By Preferred Technology
  • 5.3. By Preferred Application

6. Global Next-Generation Sequencing (NGS) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Platforms and Services)
      • 6.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
      • 6.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
      • 6.2.1.3. By Services (Sequencing Services and Data management services)
    • 6.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other)
    • 6.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
    • 6.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2019)
  • 6.3. Product Market Map

7. North America Next-Generation Sequencing (NGS) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country (United States; Canada; Mexico and Rest of North America)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. Canada Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. Mexico Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application

8. Europe Next-Generation Sequencing (NGS) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. Germany Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. United Kingdom Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. Italy Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Spain Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Asia-Pacific Next-Generation Sequencing (NGS) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. India Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. Japan Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
    • 9.3.4. South Korea Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Application
    • 9.3.5. Australia Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Application

10. Middle East and Africa Next-Generation Sequencing (NGS) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Application
    • 10.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. South America Next-Generation Sequencing (NGS) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Technology
    • 11.2.3. By End User
    • 11.2.4. By Application
    • 11.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Application
    • 11.3.2. Argentina Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Application
    • 11.3.3. Colombia Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (NGS Platform Providers)

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Illumina, Inc.
    • 14.2.2. Thermo Fisher Scientific, Inc
    • 14.2.3. BGI Group
    • 14.2.4. Perkinelmer Inc.
    • 14.2.5. Agilent Technologies, Inc.
    • 14.2.6. Pacific Biosciences of California Inc.
    • 14.2.7. F. Hoffmann-La Roche Ltd.
    • 14.2.8. 10x Genomics Inc.
    • 14.2.9. Amgen Inc.
    • 14.2.10. Takara Bio Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

(Note: The companies list can be customized based on the client requirements.)

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.